SlideShare a Scribd company logo
1 of 195
INTELLECTUAL PROPERTY
RIGHTS
& STEPS IN PATENT GRANTING
DR.M.V.NAGABHUSHANAM
PROFESSOR & HEAD OF THE DEAPRTMENT
DEPARTMENT OF PHARM. MANAGEMENT & REGULATORY AFFAIRS
HINDU COLLEGE OF PHARMACY, GUNTUR A.P.
Industry size : 25.8 Bn USD
Exports : 13.2 Bn USD
Imports: 3.52 Billion USD
Industry is growing @ 20% p.a
Domestic Market 2011-2012: 12.6 Bn USD
4th Largest in world in terms of Volume & ranks 13th in terms of Value
Export of Biotech products & Biopharmaceuticals ~US $1.36 Bn
Export of Vaccines- US $507.9 million (US $ 42 Bn by year 2015)
Manufacturing Facilities 172 US FDA Approved
India Stood First Globally with 2759 DMF filling Out of 7886 DMFs
US Pharmacopoeia has office in Hyderabad, India
USFDA has country office in Delhi, Mumbai
9,000 manufacturing units in the country
600,000 Retail & Wholesale Shops in India
153 EDQM certified facilities; 6th largest supplier of HIV drugs after
Germany
Drugs from India are exported to more than 200 countries
Vaccines from India are exported to more than 151 countries
Emerging markets India and China will figure in the top 10
pharma markets of the world by 2015, an Ernst & Young
report has said. The report has identified India as the
preferred choice for outsourcing in the area of late stage drug
discovery, shared services and complex manufacturing while
China has been the preferred market for building blocks and
intermediates.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
INTELLECTUAL PROPERTY RIGHTS (IPR)
• Intellectual property rights (IPR) can be defined as
the rights given to people over the creation of
their minds. They usually give the creator an
exclusive right over the use of his/her creations for
a certain period of time.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
CATEGORIES OF INTELLECTUAL PROPERTY
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Intellectual Property rights
• Intellectual Property rights may be protected at
law in the same way as any other form of property.
Intellectual property laws vary from jurisdiction to
jurisdiction.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is Intellectual Property?
• Intellectual property is an intangible creation of the
human mind, usually expressed or translated into a
tangible form that is assigned certain rights of property.
Examples of intellectual property include an author's
copyright on a book or article, a distinctive logo design
representing a soft drink company and its products,
unique design elements of a web site, or a patent on
the process to manufacture chewing gum.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
The different types of Intellectual Property Rights are:
• i. Patents
• ii. Copyrights
• iii. Trademarks
• iv. Industrial designs
• v. Protection of Integrated Circuits layout design
• vi. Geographical indications of goods
• vii. Biological diversity
• viii. Plant varieties and farmers rights
• ix. Undisclosed information
COPYRIGHT
• 1. Writings
• 2. Paintings
• 3. Musical works
• 4. Dramatics works
• 5. Audiovisual works
• 6. Sound recordings
• 7. Photographic works
• 8. Broadcast
• 9. Sculpture
• 10. Drawings
• 11. Architectural works etc.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
INTELLECTUAL PROPERTY
INDUSTRIAL PROPERTY + COPY RIGHT
PATENTS DESIGNS TRADEMARKS Geographical Indications
PHARMACEUTICAL MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Duration of Intellectual Property Rights in
a nutshell
• Term of every patent will be 20 years from the date of
filing of patent application,
• irrespective of whether it is filed with provisional or
complete specification. Date of
• patent is the date on which the application for patent is
filed.
• 2) Term of every trademark registration is 10 years from
the date of making of the
• application which is deemed to be the date of
registration.
• 3) Copyright generally lasts for a period of sixty years.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Duration of Intellectual Property Rights in
a nutshell
• 4) The registration of a geographical indication is valid
for a period of 10 years.
• 5) The duration of registration of Chip Layout Design is
for a period of 10 years counted
• from the date of filing an application for registration or
from the date of first commercial
• exploitation anywhere in India or in any convention
country or country specified by
• Government of India whichever is earlier.
• 6) The duration of protection of registered varieties is
different for different crops namely
• 18 years for trees and vines, 15 years for other crops
and extant varieties.
Global Intellectual Property Trends
• With over 3 million applications filed per year,
trademark protection is the most sought after
form of IP worldwide
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Intellectual Property Trends – India
• During 2009-10, 34,287 patent applications were
filed, 6069 examined and 6168 patents granted.
The number of applications filed by the Indian
applicants was 7044.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
CROCIN
Crocin sells more than 2.50 million pills each
day. That's nearly 30 every second, around-the
clock Internationally Crocin goes by the name
Panadol.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• Pfizer’s cough and cold
syrup Corex is a leading
brand in India with sales
of $35.53 million (Rs 167
crore)
PHARMA MANAGEMENT & REGULATORY AFFAIRS
•
• Voveran, Novartis India’s flagship pain killer
medicine, is the second leading brand with
sales of $31.63 million (Rs 148.7 crore) with
growth rate of 4 percent.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• Phensedyl cough and cold syrup from Piramal
Healthcare is the third leading brand in India and it
registered a growth of over 50 percent.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• A human insulin product from Novo Nordisk—
Human Mixtard 30/70 which stands fourth in the
top 10 brands of India has registered a growth of
just three percent, according to ORG-IMS
Research.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
•
• Franco- Indian Pharma’s anaemia drug Dexorange,
Pfizer’s cough and cold syrup Corex have registered
a doubledigit growth.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Introduction
• 1856 - George Alfred DePenning, a civil engineer, is
supposed to have made the first application
for a patent in India for his invention –
"An Efficient Punkah Pulling Machine" .
• March 3- Petition to the Government of India for grant of
exclusive privileges for his inventions.
• Sept. 2 – Submission of Specifications for his invention
along with drawings to illustrate its working.
• These were accepted and the invention was granted the
first ever Intellectual Property protection in India.
Department of Pharmaceutical Management And Regulatory Affairs
History of Patent Law
Department of Pharmaceutical Management And Regulatory Affairs
YEAR ACTS
1856
THE ACT VI OF 1856 ON PROTECTION OF
INVENTIONS BASED ON THE BRITISH
PATENT LAW OF 1852. CERTAIN EXCLUSIVE
PRIVILEGES GRANTED TO INVENTORS OF
NEW MANUFACTURERS FOR A PERIOD OF
14 YEARS.
1859
THE ACT MODIFIED AS ACT XV; PATENT
MONOPOLIES CALLED EXCLUSIVE
PRIVILEGES (MAKING. SELLING AND USING
INVENTIONS IN INDIA AND AUTHORIZING
OTHERS TO DO SO FOR 14 YEARS FROM
DATE OF FILING SPECIFICATION).
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• 1872 THE PATENTS & DESIGNS PROTECTION ACT.
• 1883 THE PROTECTION OF INVENTIONS ACT.
• 1888 CONSOLIDATED AS THE INVENTIONS & DESIGNS ACT.
• 1911 THE INDIAN PATENTS & DESIGNS ACT.
• 1972 THE PATENTS ACT (ACT 39 OF 1970) CAME INTO FORCE ON
20
TH
APRIL 1972.
• 1999 ON MARCH 26, 1999 PATENTS (AMENDMENT) ACT, (1999)
CAME INTO FORCE FROM 01-01-1995.
• 2002 THE PATENTS (AMENDMENT) ACT 2002 CAME INTO FORCE
FROM 2OTH MAY 2003
• 2005 THE PATENTS (AMENDMENT) ACT 2005 EFFECTIVE FROM Ist
JANUARY 2005
History of Patent Law
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Patent Filing Procedures
• Step 1: Filing of Patent Application
• Step 2: Publication
• Step 3: Opposition (if any)
• Pre grant Opposition ; Post grant Opposition
• Step 4: Request for Examination
• Step 5: First Examination Report
• Step 6: Amendment of objections by the applicant
• Step 7: Grant of Patent
• Step 8: Renewal fees
PHARMA MANAGEMENT & REGULATORY AFFAIRS
HISTORY OF COPYRIGHT LAW
1847
• Copyright law entered India through an enactment.
• According to the 1847 enactment, the term of copyright was for the lifetime
of the author + seventy years post-mortem.
Purpose:
• Specifically reserves the subsistence of copyright in the author, and his right to
sue for its infringement to the extent available in law other than the 1847 Act.
 Registration of copyright with the Home Office was mandatory for the
enforcement of rights under the Act.
Department of Pharmaceutical Management And Regulatory Affairs
HISTORY OF COPYRIGHT LAW
1914:
• Indian legislature enacted a new Copyright Act with few modifications
• First - Introduced criminal sanctions for copyright infringement
(sections7 to 12).
• Second - Modified the scope of the term of copyright; under section 4
 Act was continued with minor adaptations and modifications till the 1957 Act
was brought into force on 24th January, 1958.
DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
COPYRIGHT ENFORCEMENT ADVISORY COUNCIL (CEAC)
• The Government has set up on November 6, 1991 a Copyright Enforcement
Advisory Council (CEAC) to review the progress of enforcement of Copyright
Act periodically and to advise the Government regarding measures for
improving the enforcement of the Act.
 Amendments:
1981
1984
1992
1994
1999
2010
2012
DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
HISTORY OF TRADEMARK LAW
1940 - The Indian Trademarks Act was passed .
1958 - The Trademark and Merchandise Act, 1958
Purpose:
• Enables the registration of trademarks so that the proprietor of the
trademark gets legal right to the exclusive use of the trademark.
Objective:
• Easy registration and better protection of trademarks and for
prevention of the use of fraudulent marks on merchandise.
1999 – The Trademark Act 1999
Objective:
• To confer the protection to the user of the trademark on his goods
and prescribe conditions on acquisition, and legal remedies for
enforcement of trademark rights.
DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
History of Geographical Indications
1999 - Geographical Indications of Goods (Registration and
Protection) Act, 1999
2002 - The Geographical Indications of Goods (Registration and
Protection) Rules, 2002
- deal with registration and better protection of
geographical indications relating to goods.
Purpose:
• Provide legal protection to Indian Geographical Indications which
in turn boost exports.
According to the Act:
The term 'geographical indication' (in relation to goods) means "an
indication which identifies such goods as agricultural goods,
natural goods or manufactured goods as originating, or
manufactured in the territory of a country, or a region or locality in
that territory.
What is a Geographical Indication?
• It is an indication
• It originates from a definite geographical territory.
• It is used to identify agricultural, natural or
manufactured goods
• The manufactured goods should be produced or
processed or prepared in that territory.
• It should have a special quality or reputation or
other characteristics
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Examples of Geographical Indication
• Solapur Chaddar
• Solapur Terry Towel
• Basmati Rice
• Darjeeling Tea
• Kanchipuram Silk Saree
• Alphanso Mango
• Nagpur Orange
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
JURISDICTION OF OFFICES
PHARMACEUTICAL MANAGEMENT & REGULATORY AFFAIRS
Organization Structure – IP Offices
Ministry of Industry & Commerce
Office of the Controller
General of Patents, Designs
And Trademarks
Designs wing
(Kolkatta)
Patent office
( Kolkatta, Delhi,
Mumbai, Chennai)
Trade Marks Registry
( Kolkatta, Delhi,
Mumbai, Ahmedabad
Chennai)
Geographical
Indications
Registry
( Chennai)
Patent
Information
Service
( Nagpur)
What is Patent?
• Patent is a grant for an invention by the Government to
the inventor in exchange for full disclosure of the
invention. A patent is an exclusive right granted by law to
applicants / assignees to make use of and exploit their
inventions for a limited period of time (generally 20 years
from filing).
PHARMA MANAGEMENT & REGULATORY AFFAIRS
57
PATENT
• A Legal Right
• Conferred by the state
• To an applicant / inventor
• For Disclosing a New
invention
• To make, use, sell or
license the invention
• For a limited period
Pharmaceutical Management & Regulatory Affairs
PATENTS
• As on date, India is fully in compliance with its
international obligations under the TRIPs Agreement.
• The Patents Act 1970 has undergone three
amendments – 1999, 2002 & 2005.
• Introduction of product patent protection for food,
pharmaceutical and chemical inventions.
* New amendment effective from January 01, 2005
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PATENTING OF PHARMACEUTICALS
• New Chemical Entities
• Process for preparing the new chemical entity
• Pharmaceutical Intermediates
• Pharmaceutical compositions of new compounds
• New pharmaceutical compositions of old compounds
• Process for preparing new compositions
• First pharmaceutical use of a known compound
• Second or new pharmaceutical use of a known
compound.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
60
CRITERIA FOR GRANTING A PATENT
• New (Novelty)
i.e invention must be new and not known earlier.
• Useful (Capable of Industrial application)
i.e. invention must work and should not be only
theoretical
• Unobvious (Involve an inventive step)
i.e. must involve some effort on part of inventor
PHARMA MANAGEMENT & REGULATORY AFFAIRS
WHAT CANNOT BE PATENTED
• According to Indian Patent Act 1970,following inventions
are not patentable
• Invention which is contrary to well established natural
laws
• Primary use of invention is injurious to public health
• Mere discovery of scientific principle or the formulation of
an abstract theory
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Arrangement or rearrangement or duplication of known devices
A method of agriculture or horticulture
 Any process for the medicinal, surgical, curative, prophylactic or
other treatment of human beings or any process for similar
treatment of animals or plants
 A presentation of information
 A mathematical or business method or a computer programme
or algorithms
PHARMA MANAGEMENT & REGULATORY AFFAIRS
WHAT CANNOT BE PATENTED
Office Territorial Jurisdiction
• Patent Office Branch, Mumbai
• The States of Maharashtra, Gujarat, Madhya
Pradesh,
• Goa and Chhattisgarh and the Union Territories of
• Daman and Diu & Dadra and Nagar Haveli
• Patent Office Branch, Chennai
• The States of Andhra Pradesh, Karnataka, Kerala,
Tamil
• Nadu and the Union Territories of Pondicherry and
• Lakshadweep.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Office Territorial Jurisdiction
• Patent Office Branch, New Delhi
• The States of Haryana, Himachal Pradesh, Jammu
and
• Kashmir, Punjab, Rajasthan, Uttar Pradesh,
Uttaranchal,
• Delhi and the Union Territory of Chandigarh.
• Patent Office, Kolkata The rest of India
PHARMA MANAGEMENT & REGULATORY AFFAIRS
LICENSING AND THE GOVERNMENT
Or
How to negotiate a successful
partnership.
Pharma Management & Regulatory Affairs
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is a License?
• A contract between licensor and licensee.
• Licensor grants to licensee the right to practice the
technology claimed in the licensed patent
• Licensor agrees not to sue licensee for infringing licensor’s
patent
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Types Of Patent Applications
• 1) Ordinary Application
• 2) Application for Patent of Addition (granted for
Improvement or Modification of the
• already patented invention, for an unexpired term of
the main patent).
• 3) Divisional Application (in case of plurality of
inventions disclosed in the main
• application).
• 4) Convention application, claiming priority date on the
basis of filing in Convention
• Countries.
• 5) National Phase Application under PCT.
How is a patent obtained?
• File an application for patent With one of the patent offices based on
territorial jurisdiction of the place of office or residence of the applicant
/agent
• Pay the required fee
• Information concerning application form and details of fee available at
• www.ipindia.nic.in
• Guidelines for applicants also available on this website
• The Patent Office then Conducts searches to ascertain the prerequisites
• - Publishes the application
• - Conducts in-depth examination
• - Raises objection to the application
• - Grants the patent
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Patent Grant Procedure
Filing of patent application
Publication after 18 months
Pre Grant Opposition /
Representation by any person.
Request for examination
Examination: Grant or Refusal
Publication of Grant of patent
Post Grant Opposition to grant of patent
(Constitution of Opposition Board)
Early Publication
Decision By Controller
Who can apply for Patent?
• The inventor may make an application, either
alone or jointly with another, or his/their assignee
• or legal representative of any deceased inventor or
his assignee.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Specifications
• Provisional Application for patent may be accompanied by the
provisional specification. It should contain the description of invention
with drawing, if required. It is not necessary to include Claim. However,
the complete specification should be fairly based on the matter disclosed
in the provisional specification and should be filed within 12 months.
• If the complete specification is not filed within 12 months the application
is deemed to have been abandoned. Usually a provisional specification is
filed to establish priority of the invention in case the disclosed invention
is only at a conceptual stage and a delay is expected in submitting full
and specific description of the invention. Although, a patent application
accompanied with provisional specification does not confer any legal
patent rights to the applicants, it is, however, a very important document
to establish the earliest ownership of an invention. specification
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Complete specification
• The complete specification is an essential document in the
filing of patent application along with the drawing to be
attached according to the necessity. Complete specification
should fully describe the invention with reference to
drawing, if required, disclosing the best method known to
the applicant and end with Claim/Claims defining the scope
of protection sought.. The specification must be written in
such a manner that person of ordinary skill in the relevant
field, to which the invention pertains, can understand the
invention.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• Normally, it should contain the following matter-
• Title of invention,
• 2) Field of invention,
• 3) Background of invention with regard to the drawback
associated with known art,
• 4) Object of invention,
• 5) Statement of invention,
• 6) A summary of invention,
• 53
• 7) A brief description of the accompanying drawing,
• 8) Detailed description of the invention with reference to
drawing/examples,
• 9) Claim(s),
Complete specification
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is e-Filing?
• E-filing is a service provided by the Intellectual
Property Office, India in order to enable
• customers to apply for a patent on-line
allowing from the User’s browser for the User
to:
• • Complete an electronic application form •
Provide the associated attachments •
Complete
• the necessary payment details
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
COPY RIGHT
• Copy right is a exclusive right which an author acquires for
his work of literary or artistic nature such as book, a
painting, a sculpture, a photograph, a motion picture..etc
• It is a right to print, multiple, publish or sell a work.
Pharma Management & Regulatory AffairsPHARMA MANAGEMENT & REGULATORY AFFAIRS
COPYRIGHT
• The economic right given to creators of literary and
artistic works.
• Includes the rights to:
Reproduce the work
Make copies
Perform or display the work publicly
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Copyright holders have the right to…
…stop other parties from…
1. Making copies of the work.
2. Making changes to the work or creating new works
based on the original work.
3. Distributing the work.
4. Publishing the work.
5. Licensing the work to others.
6. Otherwise exploiting the work.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Duration of copy right protection
• Original literary, dramatic, artistic or musical works: the
life time of the author + period of 70 yrs from the end of
the year in which the author dies
• Computer generated works: 50 yrs from the date of
creation of work.
• Sound recordings: 50 yrs from the end of year in which it
was made or published.
• Broadcasts: 50 yrs from the end of year of broadcast
• Typographical arrangement of published editions: 25 yrs
from the year of 1st publication
PHARMA MANAGEMENT & REGULATORY AFFAIRS
WHAT IS A VALID COPYRIGHT NOTICE?
• A copyright should contain:
1. The word “Copyright”
2. A “c” in a circle (©)
3. The date of publication, AND
4. The name of either the author or the owner of all
the rights
5. “All Rights Reserved”
• EXAMPLE: A Year in Provence. Copyright © 1989
by Peter Mayle. All Rights Reserved.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
HOW TO REGISTER YOUR WORK
• Registering a copyright is a simple process:
– Fill out the appropriate form for the type of work you
are registering.
– Enclose a deposit of one or two samples of the work
(depending on what type of work it is)
– Pay the fee per registration (if you are registering several
works that are part of one series, you may register the
works together as a group registration).
PHARMA MANAGEMENT & REGULATORY AFFAIRS
TRADEMARK
• Trademarks are commercial source indicators, distinctive
signs that identify certain goods or services produced or
provided by a specific person or enterprise.
• Trademark helps consumers to identify and purchase a
product or service based on whether its specific
characteristics and quality – as indicated by its unique
trademark – meet their needs
• Must prosecute infringement of trademark or risk losing the
mark yourself!!
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is Trademark?
• A trade mark (popularly known as brand name) in
layman’s language is a visual symbol which
• may be a word signature, name, device, label,
numerals or combination of colours used by one
• undertaking on goods or services or other articles
of commerce to distinguish it from other
• similar goods or services originating from a
different undertaking.
Key Features of Trademark
• · Trademark must be Distinctive
• · Trademark must be used in Commerce
What is Trademark?
• The selected mark should be capable of being represented
graphically (that is in the paper
• form).
• · It should be capable of distinguishing the goods or services of one
undertaking from
• those of others.
• · It should be used or proposed to be used mark in relation to goods
or services for the
• purpose of indicating or so as to indicate a connection in the course
of trade between the
• goods or services and some person have the right to use the mark
with or without identity
• of that person.
Types of Trademark
• Trademark,
• · Servicemark,
• · Collectivemark,
• · Certification Mark
Functions of Trademark
• Trademark performs four functions –
• · It identifies the goods / or services and its
origin;
• · It guarantees its unchanged quality;
• · It advertises the goods/services;
• · It creates an image for the goods/ services.
MARKS
• Trademarks® , ™
– A trademark identifies tangible good or product of a company or individual.
• Servicemarks ®, SM
–A service mark identifies the service s of a provider. Marks used by a
company can function as both.
• Trade names
–Once a trade name was used to denote any mark descriptive of a good
or service.
–Today, it is a company business name.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
An Example of Copyright AND Trademark
• The gold-colored top of the New York Life building is
in the public domain and anyone can photograph it.
• However, that image also functions as a trademark
for the New York Life Company, and a competing
company could not use the image as a
representation of their company’s goods or
services..
PHARMA MANAGEMENT & REGULATORY AFFAIRS
TRADE SECRETS
• Any information that may be used in the operation
of a business and that is sufficiently valuable to
afford an actual or potential economic advantage.
• Examples: Formula for Coca-Cola; compilations of
information that provides a competitive advantage
(customer databases), advertising strategies
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Geographical indications
•An indication used to identify agricultural, natural or manufactured goods
originating from a definite territory in India.
•It should have a special quality or characteristics or reputation based upon the
climatic or production characteristics unique to the geographical location.
•Examples of Geographical Indications in India are Darjeeling Tea, Kanchipuram
Silk Saree, Alphonso Mango, Nagpur Orange, Kolhapuri Chappal, Bikaneri
Bhujia, etc.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
• The registration of a Geographical Indication is for
a period of ten years.
• Renewal is possible for further periods of 10 years
each.
• A trade mark is a sign which is used in the course of
trade and it distinguishes goods or services of one
enterprise from those of other enterprises.
• Geographical Indication is used to identify goods
having special characteristics originating from a
definite geographical territory.
Geographical indications
Legislative Framework of IP
Administration
CONTROLLER GENERAL OF PATENTS, DESIGNS
AND TRADEMARKS
(CGPDTM)
T M REGISTRY
DESIGN OFFICE
G.I. REGISTRY
Head Office
KOLKATA
Branch
DELHI
Branch
CHENNAI
Branch
MUMBAI
Head Office
MUMBAI
DELHI
KOLKATA
CHENNAI
A’BAD
IPTI ,NIIPM,
P.I.S. Nagpur
KOLKATA
PATENT OFFICE
CHENNAI
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Law and Regulations
• Patents Act, 1970
– Amended in
• 1999
• 2002
• 2005
• Patents Rules, 2003
– Amended in
• 2005
• 2006
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Legislative Measures -Patents
• From 1.1.1995
– Mail-Box for pharmaceutical and agrochemicals products
– Exclusive Marketing Rights
• From 1.1.2000
– Patent term increased to 20 years
– Definition of invention – inclusion of inventive step
– Reversal of burden of proof – on the infringer
– Mandatory compulsory licence provision for food, drugs and
chemicals removed
– Right of patentee (importation also included)
• From 1.1.2005
– Product patents for food, chemical and pharmaceutical
We have met our international commitments
PHARMA MANAGEMENT & REGULATORY AFFAIRS
100
Patent Law - Salient Features
• Both product and process patent provided
• Term of patent – 20 years
• Examination on request
• Both pre-grant and post-grant opposition
• Fast track mechanism for disposal of appeals
• Provision for protection of bio-diversity and traditional
knowledge
• Publication of applications after 18 months with facility for
early publication
• Substantially reduced time-lines
PHARMA MANAGEMENT & REGULATORY AFFAIRS
101
Safeguards in the Patent Law
• Compulsory license to ensure availability of drugs at
reasonable prices
• Provision to deal with public health emergency
• Revocation of patent in public interest and also on
security considerations
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Scope of Patentability Under
The Patents Act
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is an Invention?
“Invention” means a new product or process
involving an inventive step and capable of
industrial application
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Patentable subject matter
Invention must
* Relates to a process or product or both
* Be new (novel)
* Involves an inventive step
* Be capable of industrial application
PHARMA MANAGEMENT & REGULATORY AFFAIRS
“New” means
Invention must not be
Published in India or elsewhere
In prior public knowledge or prior public use with in India
Claimed before in any specification in India
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Inventive step
A feature of an invention that
• Involves technical advance as compared to
the existing knowledge or
• Have economic significance or both and
* Makes the invention not obvious to a person
skilled in the art
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Industrial application means
Invention is capable of
being made or used in any kind of
industry
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3(a)
• Frivolous inventions
• Inventions contrary to well established natural
laws
Examples
 Machine that gives more than 100% performance
 Perpetual machine
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3(b)
Commercial exploitation or primary use of
inventions, which is
Contrary to
public order or
Morality
Examples
– Gambling machine,
– Device for house-breaking ,
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3(b)
Commercial exploitation or primary use of
inventions , which
Causes serious Prejudice to
 health or
 human, animal, plant life or
 to the environment
Examples
 Biological warfare material or device,
weapons of mass destruction
 Terminator gene technology,
 Embryonic stem cell
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Checks and Balances
Section 3(b)
Excludes patents on
• GMOs – exploitation of which could be
contrary public order or morality or prejudicial
to human, animal or plant life or health or to
the environment
Effect : Only genetically modified micro-
organisms (GMOs) which do not fall under
section 3 (b) are patentable.
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3 ( c )
• Mere Discovery of a Scientific Principle or
• formulation of an Abstract Theory or
• discovery of any living thing or
• discovery of non–living substance occurring in nature
Examples
Newton’s Laws
Superconducting Phenomenon as such
Property of certain material to withstand mechanical
shock
Discovery of micro-organism
Discovery of natural gas or a mineral
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Checks and Balances
Section 3(c)
Excludes patents on
•Naturally occurring Micro-organisms
Effect
Genetically modified microorganisms (GMOs) are
however, patentable.
Section 3 exclusions
Section3 (d)
The mere discovery of a new form of a
known substance which does not result
in the enhancement of the known efficacy
of that substance
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section3 (d) Explanation
For the purposes of this clause,
• salts, esters, ethers, polymorphs,
• metabolites, pure form, particle size,
• isomers, mixture of isomers,
• complexes, combinations and other derivatives of known
substances
shall be considered to be the same substance, unless they
differ significantly in properties with regard to efficacy.
Examples
– Crystalline forms of known substance
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Checks and Balances
Section 3 (d) Explanation
Effect
Salts, esters, ethers, polymorphs, metabolite, pure
forms, particle size, isomers, complexes,
combinations and derivatives of a known substance
with enhanced efficacy are patentable
Section 3 exclusions
Section3 (d)
Mere discovery of any new property or
new use for a known substance or of the
mere use of a known process, machine or
apparatus, unless such known process
results in a new product or employs at least
one new reactant.
Examples
– New use of Aspirin for heart ailments,
– Mere new uses of Neem
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3(e)
Substance obtained by mere admixture resulting only in the
aggregation of the properties of the components thereof or a process
for producing such substance
Examples
 Combiflam [Paracetamol (Antipyretic) + Brufen (analgesic)]
 Solution of sugar and color additives in water to form a soft drink
However,
A mixture resulting into synergistic properties of mixture
of ingredients however, may be patentable - Soap,
Detergents, lubricants etc
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Checks and Balances
Section 3 ( e )
Effect
 Substance obtained by mere admixture resulting
only in the aggregation of the properties of the
components thereof or
 a process for producing such substance
are not patentable
However
Synergistic formulations are patentable
Section 3 exclusions
Section 3 ( f )
Mere arrangement or re-arrangement or
duplication of known devices, each
functioning independently of one another in
a known way
Examples
A Bucket fitted with torch,
An Umbrella with fan
A Clock and radio in a single cabinet
A flour-mill provided with sieving
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3(h)
Method of Agriculture or Horticulture
Examples
Cultivation of algae ,
Producing new form of a known plant,
Preparation of an improved soil
However,
Agricultural Equipments are patentable
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3(i)
Any process for medicinal, surgical, curative, prophylactic,
diagnostic, therapeutic or other treatment of human beings or a
similar treatment of animals to render them free of disease or to
increase their economic value or that of their products
Examples
 Removal of cancer tumor
 Removal of dental plaque and carries
 Surgical processes
 Processes relating to therapy
 Method of vaccination,
 Blood transfusion
Section 3 exclusions
However ,
Treatment performed on tissues or fluids permanently removed from the body
Surgical,therapeutic or diagnostic Apparatus or instruments
are patentablePHARMA MANAGEMENT & REGULATORY AFFAIRS
Section3 exclusions
Section 3(j)
Plants & animals in whole or any part
thereof other than micro- organisms, but
including seeds, varieties an d species and
essentially biological process for
production or propagation of plants &
animals
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 exclusions
Section 3(j)
• Plants & animals in whole
• Parts of plants & animals
• Seeds
• Varieties & species
• Essentially biological processes for
propagation or production of the animals
& plants
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Checks and Balances
Section 3(j)
Excludes patents on
• Plants and animals in whole or any parts thereof,
…… including seeds, varieties and species and
essentially biological processes for production or
propagation of plants and animals
Examples
– Clones and new varieties of plants
– A process for production of plants or animals if
it consists entirely of natural phenomena such as
crossing or selection
– Essentially biological Process
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3(k)
* mathematical method or
* business method or
* algorithms or
* computer programme per se
Examples
– Computer program by itself or as a record on a carrier
However
– New calculating machine
– combination of hardware and software
is patentable
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3(l)
A literary,dramatic, musical or artistic work or any other
aesthetic creation including cinematographic work and
television productions
These subject-matters fall under the
copyright protection
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3(m)
A mere scheme or rule or method of performing mental act or
method of playing game
Examples
•Scheme for learning a language
•Method for solving a crossword puzzle,
•Method of learning a language
•Method of teaching /learning
However,
•Novel apparatus for playing game or carrying
out a scheme is patentable
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 (n)
Presentation of information
Examples
 Any manner or method of expressing information
whether by
spoken words
Visual display
symbols
diagrams
Information recorded on a carrier
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 (o)
Topography of integrated circuits.
Examples
Mask works - circuits layout
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 3 (p)
Inventions which are
Traditional Knowledge or an aggregation or duplication of known
properties of traditionally known component or components
Examples
Traditional Knowledge already in public domain
- Wound healing property of Haldi
However,
Any value-addition using Traditional Knowledge leading to a
new process or product ,which is novel with inventive step and
industrial applicability,
Extraction of Azadirachtin from Neem
can be patented
Section 3 exclusions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Section 4
Inventions falling within Section 20(1) of the
Atomic Energy Act, 1962 are not patentable
Effect
Inventions relating to compounds of Uranium, Beryllium, Thorium, Plutonium,
Radium, Graphite, Lithium and more as notified by Central Govt. from time to time.
Non Patentable inventions
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Stages from filing to grant of a
patent
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Obtaining a patent
• File an application for patent
– With one of the patent offices based on territorial
jurisdiction of the place of office or residence of the
applicant /agent
– Pay the required fee
• Information concerning application form and details
of fee available at www.ipindia.nic.in
• Guidelines for applicants also available on this
website
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Formality Check
• An Examiner checks the formal requirements
before accepting the application and the fee –
this is done immediately
• Issue of application number and the cash
receipt – this is done the same day
• In case of receipt of application by post, cash
receipt, application number is sent by post
within 2-3 days
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Publication
• Application is kept secret for a period of 18 months
from the date of filing
• In 19th month, the application is published in the
official journal – this journal is made available on the
website weekly
• Applicant has an option to get his application
published before 18 months also
• In that case, application is published within one
month of the request
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Request for Examination
• Application is examined on request
• Request for examination can be made either
by the applicant or by a third party
• A period of 48 months, from the date of filing,
is available for making request for
examination
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Examination
• Application is sent to an Examiner within 1
month from the date of request for
examination
• Examiner undertakes examination w.r.t.
– whether the claimed invention is not prohibited
for grant of patent
– whether the invention meets the criteria of
patentability
Issue of FER
• A period of 1 to 3 months is available to
Examiner to submit the report to the
Controller
• 1 month’s time available to Controller to vet
the Examiner’s report
• First Examination Report (FER) containing gist
of the objections is issued within 6 months
from the date of filing of request
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Response from the Applicant
• 12 months’ time, from the date of issue of
FER, is available to the applicant to meet the
objections
• If objections are met, grant of patent is
approved by the Controller – within a period
of 1 month
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Pre-grant Opposition
• After publication, an opposition can be filed
within a period of 6 months
• Opportunity of hearing the opponent is also
available
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Examination of Pre-grant Opposition
• Opposition (documents) is sent to the
applicant
• A period of 3 months is allowed for receipt of
response
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Consideration of
Pre-grant Opposition
• After examining the opposition and the
submissions made during the hearing,
Controller may
– Either reject the opposition and grant the patent
– Or accept the opposition and modify/reject the
patent application
• This is to be done within a period of 1 month
from the date of completion of opposition
proceedings
Grant of a Patent
• A certificate of patent is issued within 7 days
• Grant of patent is published in the official
journal
STAGES - FILING TO GRANT OF PATENT
PUBLICATION OF APPLICATION
REQUEST FOR EXAMINATION
GRANT OF PATENT
3rd Party Representation
Revocation/Amendment
OPPOSITION
• PROMPTLY AFTER 18 MONTHS FROM P.D.
• WITHIN 48 MONTHS FROM F.D.
• ALL OBJECTIONS TO BE COMPLIED WITHIN 12
MONTHS
• IF P.S.IS FILED C.S. TO BE FILED WITHIN 12MONTHS
• WITHIN 12 MONTHS
FILING OF APPLICATION
PROVNL. / COMPLETE
Decision of
Controller
EXAMINATION-ISSUE OF FER
Appeal
Appellate Board
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Renewal Fee
• To be paid within 3+6 months from date of recording in
the register [sec 142 (4) ]
• No fee for 1st and 2nd year
• Renewal fee, on yearly basis, is required to be paid for 3rd
to 20th for keeping the patent in force
• Delay upto six months from due date permissible on
payment of fee for extension of time
• Patent lapses if renewal fee is not paid within the
prescribed period
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Indian Drug Regulatory System:
Government of India
Ministry of Health &
Family Welfare
DGHS
Central Drugs
Standard Control
Organization
(CDSCO)
Ministry of Science
& Technology
Indian Council
of Medical
Research
(ICMR)
Council of
Scientific &
Industrial
Research
(CSIR)
BARC
(Radioactive)
Ministry of Chemicals
& Petrochemicals
National
Pharmaceutical
Pricing Authority
(NPPA)
Department of
Chemical &
Petrochemicals
(DCP)
Department of
Pharmaceuticals
Ministry of
Commerce &
Industry
Patent
Office
Dept. of
Commerce &
Pharmexil
Controller
General of
Patent
DGFT
Ministry of
Environment &
Forest
GEAC-[Genetic
Engineering
Approval
Committee]
Department of
Biotechnology
r-DNA Advisory
Committee
Review
Committee
Genetic
Manipulation
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Regulatory/Apex/Committee Functions
CDSCO Central Drugs Standard Control
Organization (1948)
Laying down standards, Clearance of new drugs, CLAA
items, Banning Drugs, Clinical Trails etc.
ICMR Indian Council of Medical Research
(1911)
Formulates, Coordinates and Promotes biomedical
research & Ethical Principles
GEAC Genetic Engineering Approval
Committee (1989)
Manufacture, Use, Import of Hazards
Microorganisms/Genetically Engineered Organisms or
Cells
DBT Department of Biotechnology (1986) It promote transgenic research, molecular biology of
human genetic disorders, brain research, and
commercialization of diagnostic kits and vaccines for
communicable diseases
AERB Atomic Energy Review Board (1983) Promotes Radio therapy & Research, Safety review for
Gamma Irradiators (Devices)
BARC Bhabha Atomic Research Centre
(1967)
Promotes Isotopes application in Medicine & also
monitoring usage of radioactive materials
DTAB Drug Technical Advisory Board (1950) To advise Central & State Govt. on Technical Matters
arising out of the Drugs & Cosmetics
RCGM Review Committee on Genetic
Manipulation (1989)
No Objection Certificate for Clinical Trial & also r-DNA
strains,
DCC Drug Consultative Committee (since
1951)
Advisory Committee to DTAB and Central & State Govt.
for uniform implementation of Various provisions of the
ActPHARMA MANAGEMENT & REGULATORY AFFAIRS
Introduction to Ministry of Health & Family Welfare
(MOH&FW)
• MOH&FW comprises 04 departments each of which is headed by a Secretary to
the Govt. of India
– Department of Health & Family welfare
– Department of AYUSH
– Department of Health Research
– Department of AIDS Control
• CDSCO is a separate division comes under DGHS, headed by DCG(I)
• Public health is one of the major objectives of Govt. of India and to achieve this it
is important that drugs/vaccines are available to the public are Quality, Safety,
Purity and Efficacious.
152
PHARMA MANAGEMENT & REGULATORY AFFAIRS
153
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Goa
New Delhi
Chennai
CDSCO North Zone (Ghaziabad)
Kolkata
.
CDSCO West Zone (Mumbai)
CDSCO South Zone (Chennai)
CDSCO East Zone (Kolkata)
CDSCO, HQ
• Hyderabad
Ahmedabad
*New Zonal Offices : 2
(Ahmedabad & Hyderabad)
*Sub- Zonal Office : 3
*Port Offices/Airports : 11
*Central Laboratories : 6
35 SLAs= 29 States+ 6 UTs
Bengaluru
Geographical Location of CDSCO
Chandigarh
J&K
HQ
154
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Functions of CDSCO
Approval of new drugs and clinical trials
Import Registration and Licensing
License approving of Blood Banks, LVPs, Vaccines, r-DNA
products & some Medical Devices (CLAA Scheme)
Amendment to D &C Act and Rules
Banning of drugs and cosmetics
Grant of Test License, Personal License, NOCs for Export
Testing of New Drugs
156
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Functions of State Licensing Authorities
Licensing of Manufacturing Site for Drugs including API and
Finished Formulation
Licensing of Establishment for sale or distribution of Drugs
Approval of Drug Testing Laboratories
Monitoring of Quality of Drugs and Cosmetics marketed in the
country
Investigation and prosecution in respect of contravention of
legal provision
Recall of sub-standard drugs
157
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Principles of GLP and Regulatory requirements
Objectives of GLP
• GLP makes sure that the data submitted are a true
reflection of the results that are obtained during the study.
• GLP also makes sure that data is traceable.
• Promotes international acceptance of tests.
158
PHARMA MANAGEMENT & REGULATORY AFFAIRS
What is GLP?
• Good Laboratory Practice (GLP) deals with the organization, process and conditions under which
laboratory studies are planned, performed, monitored, recorded, reported & archived. GLP
practices are intended to promote the quality and validity of test data (part 58 CFR 21). OR
• GLP is a quality system concerned with the organizational process and the conditions under which
non clinical health & environmental safety studies are planned, performed, monitored, recorded,
archived & reported. (Ref. Jurg P. Seiler-Switzerland, GLP, 2nd edition by Springer publication,
2005, Page 61).
• Schedule L-I regulations and guidelines have a significant impact on the daily operation of an
analytical laboratory.
• GLP is a regulation. It is not only good analytical practice. Good analytical practice is important,
but it is not enough. For example, the laboratory must have a specific organizational structure and
procedures to perform and document laboratory work. The objective is not only quality of data
but also traceability and integrity of data. But the biggest difference between GLP and Non-GLP
work is the type and amount of documentation.
159
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Pharmaceutical product
Submitted to regulatory authority
Verification
Repetition of experiment or Reconstruction of all
activities activities
(Direct confirmation) (Indirect confirmation)
Judgment taken
Accept / Reject
160
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Part 1
Management and infrastructure
• Organization and management
• Quality management system
• Control of documentation
• Records
• Data-processing equipment
• Personnel
• Premises
• Equipment, instruments and
other devices
• Contracts
Part 2 Materials,
equipment, instruments
and other devices
• Reagents
• Reference substances
and reference materials
• Calibration, verifi cation
of performance and
• qualification of
equipment, instruments
and other devices
• Traceability
Part 3 Working
procedures
• Incoming samples
• Analytical
worksheet
• Validation of
analytical
procedures
• Testing
• Evaluation of test
results
• Certificate of
analysis
• Retained samples
Part 4
Safety
• General
rules
161
PHARMA MANAGEMENT & REGULATORY AFFAIRS
GLP
Internal Quality
System Audits
General Requirements Premises
Personal
Equipments
Chemicals and Reagents
Quality System
Microbiological Cultures
Reference Materials
Maintenance, Calibration,
and
Validation of Equipments
Good House Keeping
and SafetyManagement Review
Standard Operating
Procedures
Protocols and
Specifications Archive
Raw Data
Storage and Archival
162
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
PHARMA MANAGEMENT & REGULATORY AFFAIRS
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures
Intellectual property rights & Patent filing Procedures

More Related Content

What's hot

Intellectual property rights (IPR)
Intellectual property rights (IPR)Intellectual property rights (IPR)
Intellectual property rights (IPR)Sagar Savale
 
Indian patent act 1970
Indian patent act 1970Indian patent act 1970
Indian patent act 1970Sagar Savale
 
The rights and limitations of patentee ppt
The rights and limitations of patentee pptThe rights and limitations of patentee ppt
The rights and limitations of patentee pptPUTTU GURU PRASAD
 
Filing a patent application
Filing a patent applicationFiling a patent application
Filing a patent applicationNasimaKhatun10
 
Patent infringement.
Patent infringement.Patent infringement.
Patent infringement.johnsonmj
 
The patent prosecution system of india, us assignment
The patent prosecution system of india, us assignmentThe patent prosecution system of india, us assignment
The patent prosecution system of india, us assignmentAbhishek Mishra
 
Introduction to Patent Law
Introduction to Patent LawIntroduction to Patent Law
Introduction to Patent LawMichael E. Dukes
 
Key terms of Patent Act Term #6: Anticipation
Key terms of Patent Act Term #6: AnticipationKey terms of Patent Act Term #6: Anticipation
Key terms of Patent Act Term #6: AnticipationOrigiin IP Solutions LLP
 
Patent search analysis and report
Patent search analysis and reportPatent search analysis and report
Patent search analysis and reportYash Patel
 
Patent Cooperation Treaty (PCT) drafting
Patent Cooperation Treaty (PCT) draftingPatent Cooperation Treaty (PCT) drafting
Patent Cooperation Treaty (PCT) draftingDilip Darade
 
International Patent Application - PCT Route
International Patent Application -  PCT RouteInternational Patent Application -  PCT Route
International Patent Application - PCT RouteIntepat IP
 
Presentation on the Patent Process in US
Presentation on the Patent Process in USPresentation on the Patent Process in US
Presentation on the Patent Process in USBananaIP Counsels
 

What's hot (20)

Intellectual property rights (IPR)
Intellectual property rights (IPR)Intellectual property rights (IPR)
Intellectual property rights (IPR)
 
Indian patent act 1970
Indian patent act 1970Indian patent act 1970
Indian patent act 1970
 
The rights and limitations of patentee ppt
The rights and limitations of patentee pptThe rights and limitations of patentee ppt
The rights and limitations of patentee ppt
 
Patent infringements
Patent infringementsPatent infringements
Patent infringements
 
Patent process and Drafting
Patent process and DraftingPatent process and Drafting
Patent process and Drafting
 
Filing a patent application
Filing a patent applicationFiling a patent application
Filing a patent application
 
Patent
PatentPatent
Patent
 
Patent infringement.
Patent infringement.Patent infringement.
Patent infringement.
 
Compulsory license
Compulsory licenseCompulsory license
Compulsory license
 
PCT
PCTPCT
PCT
 
The patent prosecution system of india, us assignment
The patent prosecution system of india, us assignmentThe patent prosecution system of india, us assignment
The patent prosecution system of india, us assignment
 
Us patent process
Us patent processUs patent process
Us patent process
 
Introduction to Patent Law
Introduction to Patent LawIntroduction to Patent Law
Introduction to Patent Law
 
Key terms of Patent Act Term #6: Anticipation
Key terms of Patent Act Term #6: AnticipationKey terms of Patent Act Term #6: Anticipation
Key terms of Patent Act Term #6: Anticipation
 
Compulsory licensing (patents)
Compulsory licensing (patents)Compulsory licensing (patents)
Compulsory licensing (patents)
 
Patent search analysis and report
Patent search analysis and reportPatent search analysis and report
Patent search analysis and report
 
Patent Cooperation Treaty (PCT) drafting
Patent Cooperation Treaty (PCT) draftingPatent Cooperation Treaty (PCT) drafting
Patent Cooperation Treaty (PCT) drafting
 
International Patent Application - PCT Route
International Patent Application -  PCT RouteInternational Patent Application -  PCT Route
International Patent Application - PCT Route
 
Presentation on the Patent Process in US
Presentation on the Patent Process in USPresentation on the Patent Process in US
Presentation on the Patent Process in US
 
Patent processing & filling
Patent processing & fillingPatent processing & filling
Patent processing & filling
 

Viewers also liked

Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rightsharshhanu
 
Introduction to Intellectual Property Rights
Introduction to Intellectual Property RightsIntroduction to Intellectual Property Rights
Introduction to Intellectual Property RightsJamil AlKhatib
 
Patent Right
Patent RightPatent Right
Patent RightAjilal
 
Patent Filing & Grant Procedures
Patent Filing & Grant ProceduresPatent Filing & Grant Procedures
Patent Filing & Grant ProceduresPooja Shree
 
Basics of Specification Drafting- A Presentation by Somshekhar Ramkrishana
Basics of Specification Drafting- A Presentation by Somshekhar RamkrishanaBasics of Specification Drafting- A Presentation by Somshekhar Ramkrishana
Basics of Specification Drafting- A Presentation by Somshekhar RamkrishanaBananaIP Counsels
 
Introduction to intellectual property
Introduction to intellectual propertyIntroduction to intellectual property
Introduction to intellectual propertyRaja Selvam
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property RightsAjay Poshak
 
Patent opposition procedure
Patent opposition procedurePatent opposition procedure
Patent opposition procedureAltacit Global
 
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...Rahul Dev
 
Patents_Benefits and Procedure in India
Patents_Benefits and Procedure in IndiaPatents_Benefits and Procedure in India
Patents_Benefits and Procedure in Indiapandurangiabhishek
 
Intellectual Property Management Learning Module
Intellectual Property Management Learning ModuleIntellectual Property Management Learning Module
Intellectual Property Management Learning ModuleEnterpriseCulturalHeritage
 
Intellectual property rights agricultural extension
Intellectual property rights agricultural extensionIntellectual property rights agricultural extension
Intellectual property rights agricultural extensionCatherine Cathy
 
Process of patent filling,patent infringement & its issues (1)
Process of patent filling,patent infringement & its issues (1)Process of patent filling,patent infringement & its issues (1)
Process of patent filling,patent infringement & its issues (1)Ankit Puri
 
Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Hemanga Hazarika
 
Copy right ppt in intellectual property rights
Copy right ppt in intellectual property rightsCopy right ppt in intellectual property rights
Copy right ppt in intellectual property rightsSRINIVASULU N V
 

Viewers also liked (20)

Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rights
 
Introduction to Intellectual Property Rights
Introduction to Intellectual Property RightsIntroduction to Intellectual Property Rights
Introduction to Intellectual Property Rights
 
Patent Right
Patent RightPatent Right
Patent Right
 
Intellectual Property Rights (IPR)
Intellectual Property Rights (IPR)Intellectual Property Rights (IPR)
Intellectual Property Rights (IPR)
 
Patent Filing & Grant Procedures
Patent Filing & Grant ProceduresPatent Filing & Grant Procedures
Patent Filing & Grant Procedures
 
Basics of Specification Drafting- A Presentation by Somshekhar Ramkrishana
Basics of Specification Drafting- A Presentation by Somshekhar RamkrishanaBasics of Specification Drafting- A Presentation by Somshekhar Ramkrishana
Basics of Specification Drafting- A Presentation by Somshekhar Ramkrishana
 
Introduction to intellectual property
Introduction to intellectual propertyIntroduction to intellectual property
Introduction to intellectual property
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rights
 
Patent opposition procedure
Patent opposition procedurePatent opposition procedure
Patent opposition procedure
 
Patent application filing procedure
Patent application filing procedurePatent application filing procedure
Patent application filing procedure
 
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...
How To Protect Your Idea - Outlook Money Publication - Patent Filing Procedur...
 
Patents_Benefits and Procedure in India
Patents_Benefits and Procedure in IndiaPatents_Benefits and Procedure in India
Patents_Benefits and Procedure in India
 
Intellectual Property Management Learning Module
Intellectual Property Management Learning ModuleIntellectual Property Management Learning Module
Intellectual Property Management Learning Module
 
Intellectual property rights agricultural extension
Intellectual property rights agricultural extensionIntellectual property rights agricultural extension
Intellectual property rights agricultural extension
 
Process of patent filling,patent infringement & its issues (1)
Process of patent filling,patent infringement & its issues (1)Process of patent filling,patent infringement & its issues (1)
Process of patent filling,patent infringement & its issues (1)
 
Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals Intellectual Property Rights of Pharmaceuticals
Intellectual Property Rights of Pharmaceuticals
 
Copy right ppt in intellectual property rights
Copy right ppt in intellectual property rightsCopy right ppt in intellectual property rights
Copy right ppt in intellectual property rights
 
Types of patents
Types of patentsTypes of patents
Types of patents
 
Patent ppt
Patent pptPatent ppt
Patent ppt
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rights
 

Similar to Intellectual property rights & Patent filing Procedures

Mohit dra patent act amentment ppt
Mohit dra patent act amentment pptMohit dra patent act amentment ppt
Mohit dra patent act amentment pptMOHIT KUMAR VERMA
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property RightsAnupriyaNR
 
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual property
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual propertyBOT-353 Model & Imp QA-VYP-2023.pdf intellectual property
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual propertysomnathdahiphale
 
Pharmaceutical Patenting in India.
Pharmaceutical Patenting in India.Pharmaceutical Patenting in India.
Pharmaceutical Patenting in India.TanyaJain131
 
Patenting and Regulatory Requirements of Natural Products.pptx
Patenting and Regulatory Requirements of Natural Products.pptxPatenting and Regulatory Requirements of Natural Products.pptx
Patenting and Regulatory Requirements of Natural Products.pptxSonaliGadge4
 
IP for Accountants Companion launch presentation
IP for Accountants   Companion launch presentationIP for Accountants   Companion launch presentation
IP for Accountants Companion launch presentationNicholas Weston Lawyers
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property RightsVINAYKUMARGOBBURI
 
Intellectual property litigations: A case study of Anticancer drug Glivec in ...
Intellectual property litigations: A case study of Anticancer drug Glivec in ...Intellectual property litigations: A case study of Anticancer drug Glivec in ...
Intellectual property litigations: A case study of Anticancer drug Glivec in ...Dr Shahid Saache
 
Indian patent act - 1970
Indian patent act - 1970Indian patent act - 1970
Indian patent act - 1970VanithaVaniN1
 
PATENT ACT IN PHARMACY
PATENT ACT IN PHARMACYPATENT ACT IN PHARMACY
PATENT ACT IN PHARMACYRoshan Bodhe
 

Similar to Intellectual property rights & Patent filing Procedures (20)

Mohit dra patent act amentment ppt
Mohit dra patent act amentment pptMohit dra patent act amentment ppt
Mohit dra patent act amentment ppt
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rights
 
IPR 123.pptx
IPR 123.pptxIPR 123.pptx
IPR 123.pptx
 
Rohit sir ppt
Rohit sir pptRohit sir ppt
Rohit sir ppt
 
Details in Patent
Details in PatentDetails in Patent
Details in Patent
 
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual property
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual propertyBOT-353 Model & Imp QA-VYP-2023.pdf intellectual property
BOT-353 Model & Imp QA-VYP-2023.pdf intellectual property
 
Pharmaceutical Patenting in India.
Pharmaceutical Patenting in India.Pharmaceutical Patenting in India.
Pharmaceutical Patenting in India.
 
Patenting and Regulatory Requirements of Natural Products.pptx
Patenting and Regulatory Requirements of Natural Products.pptxPatenting and Regulatory Requirements of Natural Products.pptx
Patenting and Regulatory Requirements of Natural Products.pptx
 
Patent.pptx
Patent.pptxPatent.pptx
Patent.pptx
 
Patent
PatentPatent
Patent
 
CL PPT
CL PPTCL PPT
CL PPT
 
Intellectual property rights
Intellectual property rightsIntellectual property rights
Intellectual property rights
 
ip-P,TM,ID
ip-P,TM,IDip-P,TM,ID
ip-P,TM,ID
 
Patent act
Patent actPatent act
Patent act
 
IP for Accountants Companion launch presentation
IP for Accountants   Companion launch presentationIP for Accountants   Companion launch presentation
IP for Accountants Companion launch presentation
 
Intellectual Property Rights
Intellectual Property RightsIntellectual Property Rights
Intellectual Property Rights
 
Intellectual property litigations: A case study of Anticancer drug Glivec in ...
Intellectual property litigations: A case study of Anticancer drug Glivec in ...Intellectual property litigations: A case study of Anticancer drug Glivec in ...
Intellectual property litigations: A case study of Anticancer drug Glivec in ...
 
Indian patent act - 1970
Indian patent act - 1970Indian patent act - 1970
Indian patent act - 1970
 
IPR.pptx
IPR.pptxIPR.pptx
IPR.pptx
 
PATENT ACT IN PHARMACY
PATENT ACT IN PHARMACYPATENT ACT IN PHARMACY
PATENT ACT IN PHARMACY
 

Recently uploaded

Digital Marketing Courses In Pune- school Of Internet Marketing
Digital Marketing Courses In Pune- school Of Internet MarketingDigital Marketing Courses In Pune- school Of Internet Marketing
Digital Marketing Courses In Pune- school Of Internet MarketingShauryaBadaya
 
Digital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigiKarishma
 
Unlocking Passive Income: The Power of Affiliate Marketing
Unlocking Passive Income: The Power of Affiliate MarketingUnlocking Passive Income: The Power of Affiliate Marketing
Unlocking Passive Income: The Power of Affiliate MarketingDaniel
 
Infographics about SEO strategies and uses
Infographics about SEO strategies and usesInfographics about SEO strategies and uses
Infographics about SEO strategies and usesbhavanirupeshmoksha
 
A Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainA Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainBanyanbrain
 
top marketing posters - Fresh Spar Technologies - Manojkumar C
top marketing posters - Fresh Spar Technologies - Manojkumar Ctop marketing posters - Fresh Spar Technologies - Manojkumar C
top marketing posters - Fresh Spar Technologies - Manojkumar CManojkumar C
 
2024's Top PPC Tactics: Triple Your Google Ads Local Leads
2024's Top PPC Tactics: Triple Your Google Ads Local Leads2024's Top PPC Tactics: Triple Your Google Ads Local Leads
2024's Top PPC Tactics: Triple Your Google Ads Local LeadsSearch Engine Journal
 
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...CIO Business World
 
5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software SolutionsDevherds Software Solutions
 
Codes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxCodes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxGeorgeCulica
 
From Chance to Choice - Tactical Link Building for International SEO
From Chance to Choice - Tactical Link Building for International SEOFrom Chance to Choice - Tactical Link Building for International SEO
From Chance to Choice - Tactical Link Building for International SEOSzymon Słowik
 
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdf
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdfDIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdf
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdfmayanksharma0441
 
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdf
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdfDigital Marketing Spotlight: Lifecycle Advertising Strategies.pdf
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdfDemandbase
 
Influencer Marketing Power point presentation
Influencer Marketing  Power point presentationInfluencer Marketing  Power point presentation
Influencer Marketing Power point presentationdgtivemarketingagenc
 
Storyboards for my Final Major Project Video
Storyboards for my Final Major Project VideoStoryboards for my Final Major Project Video
Storyboards for my Final Major Project VideoSineadBidwell
 
Michael Kors marketing assignment swot analysis
Michael Kors marketing assignment swot analysisMichael Kors marketing assignment swot analysis
Michael Kors marketing assignment swot analysisjunaid794917
 
Common Culture: Paul Willis Symbolic Creativity
Common Culture: Paul Willis Symbolic CreativityCommon Culture: Paul Willis Symbolic Creativity
Common Culture: Paul Willis Symbolic CreativityMonishka Adhikari
 
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfResearch and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfVWO
 
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...LazarinaStoyanova
 
SEO and Digital PR - How to Connect Your Teams to Maximise Success
SEO and Digital PR - How to Connect Your Teams to Maximise SuccessSEO and Digital PR - How to Connect Your Teams to Maximise Success
SEO and Digital PR - How to Connect Your Teams to Maximise SuccessLiv Day
 

Recently uploaded (20)

Digital Marketing Courses In Pune- school Of Internet Marketing
Digital Marketing Courses In Pune- school Of Internet MarketingDigital Marketing Courses In Pune- school Of Internet Marketing
Digital Marketing Courses In Pune- school Of Internet Marketing
 
Digital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G AgeDigital Marketing in 5G Era - Digital Transformation in 5G Age
Digital Marketing in 5G Era - Digital Transformation in 5G Age
 
Unlocking Passive Income: The Power of Affiliate Marketing
Unlocking Passive Income: The Power of Affiliate MarketingUnlocking Passive Income: The Power of Affiliate Marketing
Unlocking Passive Income: The Power of Affiliate Marketing
 
Infographics about SEO strategies and uses
Infographics about SEO strategies and usesInfographics about SEO strategies and uses
Infographics about SEO strategies and uses
 
A Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | BanyanbrainA Comprehensive Guide to Technical SEO | Banyanbrain
A Comprehensive Guide to Technical SEO | Banyanbrain
 
top marketing posters - Fresh Spar Technologies - Manojkumar C
top marketing posters - Fresh Spar Technologies - Manojkumar Ctop marketing posters - Fresh Spar Technologies - Manojkumar C
top marketing posters - Fresh Spar Technologies - Manojkumar C
 
2024's Top PPC Tactics: Triple Your Google Ads Local Leads
2024's Top PPC Tactics: Triple Your Google Ads Local Leads2024's Top PPC Tactics: Triple Your Google Ads Local Leads
2024's Top PPC Tactics: Triple Your Google Ads Local Leads
 
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
The 10 Most Influential CMO's Leading the Way of Success, 2024 (Final file) (...
 
5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions5 Digital Marketing Tips | Devherds Software Solutions
5 Digital Marketing Tips | Devherds Software Solutions
 
Codes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptxCodes and Conventions of Film Magazine Covers.pptx
Codes and Conventions of Film Magazine Covers.pptx
 
From Chance to Choice - Tactical Link Building for International SEO
From Chance to Choice - Tactical Link Building for International SEOFrom Chance to Choice - Tactical Link Building for International SEO
From Chance to Choice - Tactical Link Building for International SEO
 
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdf
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdfDIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdf
DIGITAL MARKETING STRATEGY_INFOGRAPHIC IMAGE.pdf
 
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdf
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdfDigital Marketing Spotlight: Lifecycle Advertising Strategies.pdf
Digital Marketing Spotlight: Lifecycle Advertising Strategies.pdf
 
Influencer Marketing Power point presentation
Influencer Marketing  Power point presentationInfluencer Marketing  Power point presentation
Influencer Marketing Power point presentation
 
Storyboards for my Final Major Project Video
Storyboards for my Final Major Project VideoStoryboards for my Final Major Project Video
Storyboards for my Final Major Project Video
 
Michael Kors marketing assignment swot analysis
Michael Kors marketing assignment swot analysisMichael Kors marketing assignment swot analysis
Michael Kors marketing assignment swot analysis
 
Common Culture: Paul Willis Symbolic Creativity
Common Culture: Paul Willis Symbolic CreativityCommon Culture: Paul Willis Symbolic Creativity
Common Culture: Paul Willis Symbolic Creativity
 
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdfResearch and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
Research and Discovery Tools for Experimentation - 17 Apr 2024 - v 2.3 (1).pdf
 
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...
When to use Machine Learning Models in SEO and Which ones to use - Lazarina S...
 
SEO and Digital PR - How to Connect Your Teams to Maximise Success
SEO and Digital PR - How to Connect Your Teams to Maximise SuccessSEO and Digital PR - How to Connect Your Teams to Maximise Success
SEO and Digital PR - How to Connect Your Teams to Maximise Success
 

Intellectual property rights & Patent filing Procedures

  • 1. INTELLECTUAL PROPERTY RIGHTS & STEPS IN PATENT GRANTING DR.M.V.NAGABHUSHANAM PROFESSOR & HEAD OF THE DEAPRTMENT DEPARTMENT OF PHARM. MANAGEMENT & REGULATORY AFFAIRS HINDU COLLEGE OF PHARMACY, GUNTUR A.P.
  • 2.
  • 3. Industry size : 25.8 Bn USD Exports : 13.2 Bn USD Imports: 3.52 Billion USD Industry is growing @ 20% p.a Domestic Market 2011-2012: 12.6 Bn USD 4th Largest in world in terms of Volume & ranks 13th in terms of Value Export of Biotech products & Biopharmaceuticals ~US $1.36 Bn Export of Vaccines- US $507.9 million (US $ 42 Bn by year 2015) Manufacturing Facilities 172 US FDA Approved India Stood First Globally with 2759 DMF filling Out of 7886 DMFs US Pharmacopoeia has office in Hyderabad, India USFDA has country office in Delhi, Mumbai 9,000 manufacturing units in the country 600,000 Retail & Wholesale Shops in India 153 EDQM certified facilities; 6th largest supplier of HIV drugs after Germany Drugs from India are exported to more than 200 countries Vaccines from India are exported to more than 151 countries
  • 4. Emerging markets India and China will figure in the top 10 pharma markets of the world by 2015, an Ernst & Young report has said. The report has identified India as the preferred choice for outsourcing in the area of late stage drug discovery, shared services and complex manufacturing while China has been the preferred market for building blocks and intermediates. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 5.
  • 6. INTELLECTUAL PROPERTY RIGHTS (IPR) • Intellectual property rights (IPR) can be defined as the rights given to people over the creation of their minds. They usually give the creator an exclusive right over the use of his/her creations for a certain period of time. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 7. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 8. CATEGORIES OF INTELLECTUAL PROPERTY PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 9. Intellectual Property rights • Intellectual Property rights may be protected at law in the same way as any other form of property. Intellectual property laws vary from jurisdiction to jurisdiction. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 10. What is Intellectual Property? • Intellectual property is an intangible creation of the human mind, usually expressed or translated into a tangible form that is assigned certain rights of property. Examples of intellectual property include an author's copyright on a book or article, a distinctive logo design representing a soft drink company and its products, unique design elements of a web site, or a patent on the process to manufacture chewing gum. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 11. The different types of Intellectual Property Rights are: • i. Patents • ii. Copyrights • iii. Trademarks • iv. Industrial designs • v. Protection of Integrated Circuits layout design • vi. Geographical indications of goods • vii. Biological diversity • viii. Plant varieties and farmers rights • ix. Undisclosed information
  • 12. COPYRIGHT • 1. Writings • 2. Paintings • 3. Musical works • 4. Dramatics works • 5. Audiovisual works • 6. Sound recordings • 7. Photographic works • 8. Broadcast • 9. Sculpture • 10. Drawings • 11. Architectural works etc.
  • 13. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 14. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 15.
  • 16. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 17.
  • 18. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 19. INTELLECTUAL PROPERTY INDUSTRIAL PROPERTY + COPY RIGHT PATENTS DESIGNS TRADEMARKS Geographical Indications PHARMACEUTICAL MANAGEMENT & REGULATORY AFFAIRS
  • 20. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 21. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 22. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 23. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 24. Duration of Intellectual Property Rights in a nutshell • Term of every patent will be 20 years from the date of filing of patent application, • irrespective of whether it is filed with provisional or complete specification. Date of • patent is the date on which the application for patent is filed. • 2) Term of every trademark registration is 10 years from the date of making of the • application which is deemed to be the date of registration. • 3) Copyright generally lasts for a period of sixty years. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 25. Duration of Intellectual Property Rights in a nutshell • 4) The registration of a geographical indication is valid for a period of 10 years. • 5) The duration of registration of Chip Layout Design is for a period of 10 years counted • from the date of filing an application for registration or from the date of first commercial • exploitation anywhere in India or in any convention country or country specified by • Government of India whichever is earlier. • 6) The duration of protection of registered varieties is different for different crops namely • 18 years for trees and vines, 15 years for other crops and extant varieties.
  • 26. Global Intellectual Property Trends • With over 3 million applications filed per year, trademark protection is the most sought after form of IP worldwide PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 27. Intellectual Property Trends – India • During 2009-10, 34,287 patent applications were filed, 6069 examined and 6168 patents granted. The number of applications filed by the Indian applicants was 7044. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 28. CROCIN Crocin sells more than 2.50 million pills each day. That's nearly 30 every second, around-the clock Internationally Crocin goes by the name Panadol. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 29. • Pfizer’s cough and cold syrup Corex is a leading brand in India with sales of $35.53 million (Rs 167 crore) PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 30. • • Voveran, Novartis India’s flagship pain killer medicine, is the second leading brand with sales of $31.63 million (Rs 148.7 crore) with growth rate of 4 percent. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 31. • Phensedyl cough and cold syrup from Piramal Healthcare is the third leading brand in India and it registered a growth of over 50 percent. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 32. • A human insulin product from Novo Nordisk— Human Mixtard 30/70 which stands fourth in the top 10 brands of India has registered a growth of just three percent, according to ORG-IMS Research. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 33. • • Franco- Indian Pharma’s anaemia drug Dexorange, Pfizer’s cough and cold syrup Corex have registered a doubledigit growth. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 34. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 35. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 36.
  • 37. Introduction • 1856 - George Alfred DePenning, a civil engineer, is supposed to have made the first application for a patent in India for his invention – "An Efficient Punkah Pulling Machine" . • March 3- Petition to the Government of India for grant of exclusive privileges for his inventions. • Sept. 2 – Submission of Specifications for his invention along with drawings to illustrate its working. • These were accepted and the invention was granted the first ever Intellectual Property protection in India. Department of Pharmaceutical Management And Regulatory Affairs
  • 38. History of Patent Law Department of Pharmaceutical Management And Regulatory Affairs YEAR ACTS 1856 THE ACT VI OF 1856 ON PROTECTION OF INVENTIONS BASED ON THE BRITISH PATENT LAW OF 1852. CERTAIN EXCLUSIVE PRIVILEGES GRANTED TO INVENTORS OF NEW MANUFACTURERS FOR A PERIOD OF 14 YEARS. 1859 THE ACT MODIFIED AS ACT XV; PATENT MONOPOLIES CALLED EXCLUSIVE PRIVILEGES (MAKING. SELLING AND USING INVENTIONS IN INDIA AND AUTHORIZING OTHERS TO DO SO FOR 14 YEARS FROM DATE OF FILING SPECIFICATION). PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 39. • 1872 THE PATENTS & DESIGNS PROTECTION ACT. • 1883 THE PROTECTION OF INVENTIONS ACT. • 1888 CONSOLIDATED AS THE INVENTIONS & DESIGNS ACT. • 1911 THE INDIAN PATENTS & DESIGNS ACT. • 1972 THE PATENTS ACT (ACT 39 OF 1970) CAME INTO FORCE ON 20 TH APRIL 1972. • 1999 ON MARCH 26, 1999 PATENTS (AMENDMENT) ACT, (1999) CAME INTO FORCE FROM 01-01-1995. • 2002 THE PATENTS (AMENDMENT) ACT 2002 CAME INTO FORCE FROM 2OTH MAY 2003 • 2005 THE PATENTS (AMENDMENT) ACT 2005 EFFECTIVE FROM Ist JANUARY 2005 History of Patent Law PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 40. Patent Filing Procedures • Step 1: Filing of Patent Application • Step 2: Publication • Step 3: Opposition (if any) • Pre grant Opposition ; Post grant Opposition • Step 4: Request for Examination • Step 5: First Examination Report • Step 6: Amendment of objections by the applicant • Step 7: Grant of Patent • Step 8: Renewal fees PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 41. HISTORY OF COPYRIGHT LAW 1847 • Copyright law entered India through an enactment. • According to the 1847 enactment, the term of copyright was for the lifetime of the author + seventy years post-mortem. Purpose: • Specifically reserves the subsistence of copyright in the author, and his right to sue for its infringement to the extent available in law other than the 1847 Act.  Registration of copyright with the Home Office was mandatory for the enforcement of rights under the Act. Department of Pharmaceutical Management And Regulatory Affairs
  • 42. HISTORY OF COPYRIGHT LAW 1914: • Indian legislature enacted a new Copyright Act with few modifications • First - Introduced criminal sanctions for copyright infringement (sections7 to 12). • Second - Modified the scope of the term of copyright; under section 4  Act was continued with minor adaptations and modifications till the 1957 Act was brought into force on 24th January, 1958. DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
  • 43. COPYRIGHT ENFORCEMENT ADVISORY COUNCIL (CEAC) • The Government has set up on November 6, 1991 a Copyright Enforcement Advisory Council (CEAC) to review the progress of enforcement of Copyright Act periodically and to advise the Government regarding measures for improving the enforcement of the Act.  Amendments: 1981 1984 1992 1994 1999 2010 2012 DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
  • 44. HISTORY OF TRADEMARK LAW 1940 - The Indian Trademarks Act was passed . 1958 - The Trademark and Merchandise Act, 1958 Purpose: • Enables the registration of trademarks so that the proprietor of the trademark gets legal right to the exclusive use of the trademark. Objective: • Easy registration and better protection of trademarks and for prevention of the use of fraudulent marks on merchandise. 1999 – The Trademark Act 1999 Objective: • To confer the protection to the user of the trademark on his goods and prescribe conditions on acquisition, and legal remedies for enforcement of trademark rights. DEPARTMENT OF PHARMACEUTICAL MANAGEMENT AND REGULATORY AFFAIRS
  • 45. History of Geographical Indications 1999 - Geographical Indications of Goods (Registration and Protection) Act, 1999 2002 - The Geographical Indications of Goods (Registration and Protection) Rules, 2002 - deal with registration and better protection of geographical indications relating to goods. Purpose: • Provide legal protection to Indian Geographical Indications which in turn boost exports. According to the Act: The term 'geographical indication' (in relation to goods) means "an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory.
  • 46. What is a Geographical Indication? • It is an indication • It originates from a definite geographical territory. • It is used to identify agricultural, natural or manufactured goods • The manufactured goods should be produced or processed or prepared in that territory. • It should have a special quality or reputation or other characteristics PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 47. Examples of Geographical Indication • Solapur Chaddar • Solapur Terry Towel • Basmati Rice • Darjeeling Tea • Kanchipuram Silk Saree • Alphanso Mango • Nagpur Orange PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 48. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 49. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 50. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 51. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 52. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 53. JURISDICTION OF OFFICES PHARMACEUTICAL MANAGEMENT & REGULATORY AFFAIRS
  • 54. Organization Structure – IP Offices Ministry of Industry & Commerce Office of the Controller General of Patents, Designs And Trademarks Designs wing (Kolkatta) Patent office ( Kolkatta, Delhi, Mumbai, Chennai) Trade Marks Registry ( Kolkatta, Delhi, Mumbai, Ahmedabad Chennai) Geographical Indications Registry ( Chennai) Patent Information Service ( Nagpur)
  • 55.
  • 56. What is Patent? • Patent is a grant for an invention by the Government to the inventor in exchange for full disclosure of the invention. A patent is an exclusive right granted by law to applicants / assignees to make use of and exploit their inventions for a limited period of time (generally 20 years from filing). PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 57. 57 PATENT • A Legal Right • Conferred by the state • To an applicant / inventor • For Disclosing a New invention • To make, use, sell or license the invention • For a limited period Pharmaceutical Management & Regulatory Affairs
  • 58. PATENTS • As on date, India is fully in compliance with its international obligations under the TRIPs Agreement. • The Patents Act 1970 has undergone three amendments – 1999, 2002 & 2005. • Introduction of product patent protection for food, pharmaceutical and chemical inventions. * New amendment effective from January 01, 2005 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 59. PATENTING OF PHARMACEUTICALS • New Chemical Entities • Process for preparing the new chemical entity • Pharmaceutical Intermediates • Pharmaceutical compositions of new compounds • New pharmaceutical compositions of old compounds • Process for preparing new compositions • First pharmaceutical use of a known compound • Second or new pharmaceutical use of a known compound. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 60. 60 CRITERIA FOR GRANTING A PATENT • New (Novelty) i.e invention must be new and not known earlier. • Useful (Capable of Industrial application) i.e. invention must work and should not be only theoretical • Unobvious (Involve an inventive step) i.e. must involve some effort on part of inventor PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 61. WHAT CANNOT BE PATENTED • According to Indian Patent Act 1970,following inventions are not patentable • Invention which is contrary to well established natural laws • Primary use of invention is injurious to public health • Mere discovery of scientific principle or the formulation of an abstract theory PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 62. Arrangement or rearrangement or duplication of known devices A method of agriculture or horticulture  Any process for the medicinal, surgical, curative, prophylactic or other treatment of human beings or any process for similar treatment of animals or plants  A presentation of information  A mathematical or business method or a computer programme or algorithms PHARMA MANAGEMENT & REGULATORY AFFAIRS WHAT CANNOT BE PATENTED
  • 63. Office Territorial Jurisdiction • Patent Office Branch, Mumbai • The States of Maharashtra, Gujarat, Madhya Pradesh, • Goa and Chhattisgarh and the Union Territories of • Daman and Diu & Dadra and Nagar Haveli • Patent Office Branch, Chennai • The States of Andhra Pradesh, Karnataka, Kerala, Tamil • Nadu and the Union Territories of Pondicherry and • Lakshadweep. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 64. Office Territorial Jurisdiction • Patent Office Branch, New Delhi • The States of Haryana, Himachal Pradesh, Jammu and • Kashmir, Punjab, Rajasthan, Uttar Pradesh, Uttaranchal, • Delhi and the Union Territory of Chandigarh. • Patent Office, Kolkata The rest of India PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 65. LICENSING AND THE GOVERNMENT Or How to negotiate a successful partnership. Pharma Management & Regulatory Affairs PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 66. What is a License? • A contract between licensor and licensee. • Licensor grants to licensee the right to practice the technology claimed in the licensed patent • Licensor agrees not to sue licensee for infringing licensor’s patent PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 67. Types Of Patent Applications • 1) Ordinary Application • 2) Application for Patent of Addition (granted for Improvement or Modification of the • already patented invention, for an unexpired term of the main patent). • 3) Divisional Application (in case of plurality of inventions disclosed in the main • application). • 4) Convention application, claiming priority date on the basis of filing in Convention • Countries. • 5) National Phase Application under PCT.
  • 68. How is a patent obtained? • File an application for patent With one of the patent offices based on territorial jurisdiction of the place of office or residence of the applicant /agent • Pay the required fee • Information concerning application form and details of fee available at • www.ipindia.nic.in • Guidelines for applicants also available on this website • The Patent Office then Conducts searches to ascertain the prerequisites • - Publishes the application • - Conducts in-depth examination • - Raises objection to the application • - Grants the patent PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 69. Patent Grant Procedure Filing of patent application Publication after 18 months Pre Grant Opposition / Representation by any person. Request for examination Examination: Grant or Refusal Publication of Grant of patent Post Grant Opposition to grant of patent (Constitution of Opposition Board) Early Publication Decision By Controller
  • 70. Who can apply for Patent? • The inventor may make an application, either alone or jointly with another, or his/their assignee • or legal representative of any deceased inventor or his assignee. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 71. Specifications • Provisional Application for patent may be accompanied by the provisional specification. It should contain the description of invention with drawing, if required. It is not necessary to include Claim. However, the complete specification should be fairly based on the matter disclosed in the provisional specification and should be filed within 12 months. • If the complete specification is not filed within 12 months the application is deemed to have been abandoned. Usually a provisional specification is filed to establish priority of the invention in case the disclosed invention is only at a conceptual stage and a delay is expected in submitting full and specific description of the invention. Although, a patent application accompanied with provisional specification does not confer any legal patent rights to the applicants, it is, however, a very important document to establish the earliest ownership of an invention. specification PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 72. Complete specification • The complete specification is an essential document in the filing of patent application along with the drawing to be attached according to the necessity. Complete specification should fully describe the invention with reference to drawing, if required, disclosing the best method known to the applicant and end with Claim/Claims defining the scope of protection sought.. The specification must be written in such a manner that person of ordinary skill in the relevant field, to which the invention pertains, can understand the invention. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 73. • Normally, it should contain the following matter- • Title of invention, • 2) Field of invention, • 3) Background of invention with regard to the drawback associated with known art, • 4) Object of invention, • 5) Statement of invention, • 6) A summary of invention, • 53 • 7) A brief description of the accompanying drawing, • 8) Detailed description of the invention with reference to drawing/examples, • 9) Claim(s), Complete specification PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 74. What is e-Filing? • E-filing is a service provided by the Intellectual Property Office, India in order to enable • customers to apply for a patent on-line allowing from the User’s browser for the User to: • • Complete an electronic application form • Provide the associated attachments • Complete • the necessary payment details PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 75. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 76. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 77. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 78. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 79. COPY RIGHT • Copy right is a exclusive right which an author acquires for his work of literary or artistic nature such as book, a painting, a sculpture, a photograph, a motion picture..etc • It is a right to print, multiple, publish or sell a work. Pharma Management & Regulatory AffairsPHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 80. COPYRIGHT • The economic right given to creators of literary and artistic works. • Includes the rights to: Reproduce the work Make copies Perform or display the work publicly PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 81. Copyright holders have the right to… …stop other parties from… 1. Making copies of the work. 2. Making changes to the work or creating new works based on the original work. 3. Distributing the work. 4. Publishing the work. 5. Licensing the work to others. 6. Otherwise exploiting the work. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 82. Duration of copy right protection • Original literary, dramatic, artistic or musical works: the life time of the author + period of 70 yrs from the end of the year in which the author dies • Computer generated works: 50 yrs from the date of creation of work. • Sound recordings: 50 yrs from the end of year in which it was made or published. • Broadcasts: 50 yrs from the end of year of broadcast • Typographical arrangement of published editions: 25 yrs from the year of 1st publication PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 83. WHAT IS A VALID COPYRIGHT NOTICE? • A copyright should contain: 1. The word “Copyright” 2. A “c” in a circle (©) 3. The date of publication, AND 4. The name of either the author or the owner of all the rights 5. “All Rights Reserved” • EXAMPLE: A Year in Provence. Copyright © 1989 by Peter Mayle. All Rights Reserved. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 84. HOW TO REGISTER YOUR WORK • Registering a copyright is a simple process: – Fill out the appropriate form for the type of work you are registering. – Enclose a deposit of one or two samples of the work (depending on what type of work it is) – Pay the fee per registration (if you are registering several works that are part of one series, you may register the works together as a group registration). PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 85. TRADEMARK • Trademarks are commercial source indicators, distinctive signs that identify certain goods or services produced or provided by a specific person or enterprise. • Trademark helps consumers to identify and purchase a product or service based on whether its specific characteristics and quality – as indicated by its unique trademark – meet their needs • Must prosecute infringement of trademark or risk losing the mark yourself!! PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 86. What is Trademark? • A trade mark (popularly known as brand name) in layman’s language is a visual symbol which • may be a word signature, name, device, label, numerals or combination of colours used by one • undertaking on goods or services or other articles of commerce to distinguish it from other • similar goods or services originating from a different undertaking.
  • 87. Key Features of Trademark • · Trademark must be Distinctive • · Trademark must be used in Commerce
  • 88. What is Trademark? • The selected mark should be capable of being represented graphically (that is in the paper • form). • · It should be capable of distinguishing the goods or services of one undertaking from • those of others. • · It should be used or proposed to be used mark in relation to goods or services for the • purpose of indicating or so as to indicate a connection in the course of trade between the • goods or services and some person have the right to use the mark with or without identity • of that person.
  • 89. Types of Trademark • Trademark, • · Servicemark, • · Collectivemark, • · Certification Mark
  • 90. Functions of Trademark • Trademark performs four functions – • · It identifies the goods / or services and its origin; • · It guarantees its unchanged quality; • · It advertises the goods/services; • · It creates an image for the goods/ services.
  • 91. MARKS • Trademarks® , ™ – A trademark identifies tangible good or product of a company or individual. • Servicemarks ®, SM –A service mark identifies the service s of a provider. Marks used by a company can function as both. • Trade names –Once a trade name was used to denote any mark descriptive of a good or service. –Today, it is a company business name. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 92. An Example of Copyright AND Trademark • The gold-colored top of the New York Life building is in the public domain and anyone can photograph it. • However, that image also functions as a trademark for the New York Life Company, and a competing company could not use the image as a representation of their company’s goods or services.. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 93. TRADE SECRETS • Any information that may be used in the operation of a business and that is sufficiently valuable to afford an actual or potential economic advantage. • Examples: Formula for Coca-Cola; compilations of information that provides a competitive advantage (customer databases), advertising strategies PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 94. Geographical indications •An indication used to identify agricultural, natural or manufactured goods originating from a definite territory in India. •It should have a special quality or characteristics or reputation based upon the climatic or production characteristics unique to the geographical location. •Examples of Geographical Indications in India are Darjeeling Tea, Kanchipuram Silk Saree, Alphonso Mango, Nagpur Orange, Kolhapuri Chappal, Bikaneri Bhujia, etc. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 95. • The registration of a Geographical Indication is for a period of ten years. • Renewal is possible for further periods of 10 years each. • A trade mark is a sign which is used in the course of trade and it distinguishes goods or services of one enterprise from those of other enterprises. • Geographical Indication is used to identify goods having special characteristics originating from a definite geographical territory. Geographical indications
  • 96. Legislative Framework of IP Administration
  • 97. CONTROLLER GENERAL OF PATENTS, DESIGNS AND TRADEMARKS (CGPDTM) T M REGISTRY DESIGN OFFICE G.I. REGISTRY Head Office KOLKATA Branch DELHI Branch CHENNAI Branch MUMBAI Head Office MUMBAI DELHI KOLKATA CHENNAI A’BAD IPTI ,NIIPM, P.I.S. Nagpur KOLKATA PATENT OFFICE CHENNAI PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 98. Law and Regulations • Patents Act, 1970 – Amended in • 1999 • 2002 • 2005 • Patents Rules, 2003 – Amended in • 2005 • 2006 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 99. Legislative Measures -Patents • From 1.1.1995 – Mail-Box for pharmaceutical and agrochemicals products – Exclusive Marketing Rights • From 1.1.2000 – Patent term increased to 20 years – Definition of invention – inclusion of inventive step – Reversal of burden of proof – on the infringer – Mandatory compulsory licence provision for food, drugs and chemicals removed – Right of patentee (importation also included) • From 1.1.2005 – Product patents for food, chemical and pharmaceutical We have met our international commitments PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 100. 100 Patent Law - Salient Features • Both product and process patent provided • Term of patent – 20 years • Examination on request • Both pre-grant and post-grant opposition • Fast track mechanism for disposal of appeals • Provision for protection of bio-diversity and traditional knowledge • Publication of applications after 18 months with facility for early publication • Substantially reduced time-lines PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 101. 101 Safeguards in the Patent Law • Compulsory license to ensure availability of drugs at reasonable prices • Provision to deal with public health emergency • Revocation of patent in public interest and also on security considerations PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 102. Scope of Patentability Under The Patents Act PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 103. What is an Invention? “Invention” means a new product or process involving an inventive step and capable of industrial application PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 104. Patentable subject matter Invention must * Relates to a process or product or both * Be new (novel) * Involves an inventive step * Be capable of industrial application PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 105. “New” means Invention must not be Published in India or elsewhere In prior public knowledge or prior public use with in India Claimed before in any specification in India PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 106. Inventive step A feature of an invention that • Involves technical advance as compared to the existing knowledge or • Have economic significance or both and * Makes the invention not obvious to a person skilled in the art PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 107. Industrial application means Invention is capable of being made or used in any kind of industry PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 108. Section 3 exclusions Section 3(a) • Frivolous inventions • Inventions contrary to well established natural laws Examples  Machine that gives more than 100% performance  Perpetual machine PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 109. Section 3 exclusions Section 3(b) Commercial exploitation or primary use of inventions, which is Contrary to public order or Morality Examples – Gambling machine, – Device for house-breaking , PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 110. Section 3 exclusions Section 3(b) Commercial exploitation or primary use of inventions , which Causes serious Prejudice to  health or  human, animal, plant life or  to the environment Examples  Biological warfare material or device, weapons of mass destruction  Terminator gene technology,  Embryonic stem cell PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 111. Checks and Balances Section 3(b) Excludes patents on • GMOs – exploitation of which could be contrary public order or morality or prejudicial to human, animal or plant life or health or to the environment Effect : Only genetically modified micro- organisms (GMOs) which do not fall under section 3 (b) are patentable. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 112. Section 3 exclusions Section 3 ( c ) • Mere Discovery of a Scientific Principle or • formulation of an Abstract Theory or • discovery of any living thing or • discovery of non–living substance occurring in nature Examples Newton’s Laws Superconducting Phenomenon as such Property of certain material to withstand mechanical shock Discovery of micro-organism Discovery of natural gas or a mineral PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 113. Checks and Balances Section 3(c) Excludes patents on •Naturally occurring Micro-organisms Effect Genetically modified microorganisms (GMOs) are however, patentable.
  • 114. Section 3 exclusions Section3 (d) The mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 115. Section 3 exclusions Section3 (d) Explanation For the purposes of this clause, • salts, esters, ethers, polymorphs, • metabolites, pure form, particle size, • isomers, mixture of isomers, • complexes, combinations and other derivatives of known substances shall be considered to be the same substance, unless they differ significantly in properties with regard to efficacy. Examples – Crystalline forms of known substance PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 116. Checks and Balances Section 3 (d) Explanation Effect Salts, esters, ethers, polymorphs, metabolite, pure forms, particle size, isomers, complexes, combinations and derivatives of a known substance with enhanced efficacy are patentable
  • 117. Section 3 exclusions Section3 (d) Mere discovery of any new property or new use for a known substance or of the mere use of a known process, machine or apparatus, unless such known process results in a new product or employs at least one new reactant. Examples – New use of Aspirin for heart ailments, – Mere new uses of Neem PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 118. Section 3 exclusions Section 3(e) Substance obtained by mere admixture resulting only in the aggregation of the properties of the components thereof or a process for producing such substance Examples  Combiflam [Paracetamol (Antipyretic) + Brufen (analgesic)]  Solution of sugar and color additives in water to form a soft drink However, A mixture resulting into synergistic properties of mixture of ingredients however, may be patentable - Soap, Detergents, lubricants etc PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 119. Checks and Balances Section 3 ( e ) Effect  Substance obtained by mere admixture resulting only in the aggregation of the properties of the components thereof or  a process for producing such substance are not patentable However Synergistic formulations are patentable
  • 120. Section 3 exclusions Section 3 ( f ) Mere arrangement or re-arrangement or duplication of known devices, each functioning independently of one another in a known way Examples A Bucket fitted with torch, An Umbrella with fan A Clock and radio in a single cabinet A flour-mill provided with sieving PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 121. Section 3(h) Method of Agriculture or Horticulture Examples Cultivation of algae , Producing new form of a known plant, Preparation of an improved soil However, Agricultural Equipments are patentable Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 122. Section 3(i) Any process for medicinal, surgical, curative, prophylactic, diagnostic, therapeutic or other treatment of human beings or a similar treatment of animals to render them free of disease or to increase their economic value or that of their products Examples  Removal of cancer tumor  Removal of dental plaque and carries  Surgical processes  Processes relating to therapy  Method of vaccination,  Blood transfusion Section 3 exclusions However , Treatment performed on tissues or fluids permanently removed from the body Surgical,therapeutic or diagnostic Apparatus or instruments are patentablePHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 123. Section3 exclusions Section 3(j) Plants & animals in whole or any part thereof other than micro- organisms, but including seeds, varieties an d species and essentially biological process for production or propagation of plants & animals PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 124. Section 3 exclusions Section 3(j) • Plants & animals in whole • Parts of plants & animals • Seeds • Varieties & species • Essentially biological processes for propagation or production of the animals & plants PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 125. Checks and Balances Section 3(j) Excludes patents on • Plants and animals in whole or any parts thereof, …… including seeds, varieties and species and essentially biological processes for production or propagation of plants and animals Examples – Clones and new varieties of plants – A process for production of plants or animals if it consists entirely of natural phenomena such as crossing or selection – Essentially biological Process PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 126. Section 3(k) * mathematical method or * business method or * algorithms or * computer programme per se Examples – Computer program by itself or as a record on a carrier However – New calculating machine – combination of hardware and software is patentable Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 127. Section 3(l) A literary,dramatic, musical or artistic work or any other aesthetic creation including cinematographic work and television productions These subject-matters fall under the copyright protection Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 128. Section 3(m) A mere scheme or rule or method of performing mental act or method of playing game Examples •Scheme for learning a language •Method for solving a crossword puzzle, •Method of learning a language •Method of teaching /learning However, •Novel apparatus for playing game or carrying out a scheme is patentable Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 129. Section 3 (n) Presentation of information Examples  Any manner or method of expressing information whether by spoken words Visual display symbols diagrams Information recorded on a carrier Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 130. Section 3 (o) Topography of integrated circuits. Examples Mask works - circuits layout Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 131. Section 3 (p) Inventions which are Traditional Knowledge or an aggregation or duplication of known properties of traditionally known component or components Examples Traditional Knowledge already in public domain - Wound healing property of Haldi However, Any value-addition using Traditional Knowledge leading to a new process or product ,which is novel with inventive step and industrial applicability, Extraction of Azadirachtin from Neem can be patented Section 3 exclusions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 132. Section 4 Inventions falling within Section 20(1) of the Atomic Energy Act, 1962 are not patentable Effect Inventions relating to compounds of Uranium, Beryllium, Thorium, Plutonium, Radium, Graphite, Lithium and more as notified by Central Govt. from time to time. Non Patentable inventions PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 133. Stages from filing to grant of a patent PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 134. Obtaining a patent • File an application for patent – With one of the patent offices based on territorial jurisdiction of the place of office or residence of the applicant /agent – Pay the required fee • Information concerning application form and details of fee available at www.ipindia.nic.in • Guidelines for applicants also available on this website PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 135. Formality Check • An Examiner checks the formal requirements before accepting the application and the fee – this is done immediately • Issue of application number and the cash receipt – this is done the same day • In case of receipt of application by post, cash receipt, application number is sent by post within 2-3 days PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 136. Publication • Application is kept secret for a period of 18 months from the date of filing • In 19th month, the application is published in the official journal – this journal is made available on the website weekly • Applicant has an option to get his application published before 18 months also • In that case, application is published within one month of the request PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 137. Request for Examination • Application is examined on request • Request for examination can be made either by the applicant or by a third party • A period of 48 months, from the date of filing, is available for making request for examination PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 138. Examination • Application is sent to an Examiner within 1 month from the date of request for examination • Examiner undertakes examination w.r.t. – whether the claimed invention is not prohibited for grant of patent – whether the invention meets the criteria of patentability
  • 139. Issue of FER • A period of 1 to 3 months is available to Examiner to submit the report to the Controller • 1 month’s time available to Controller to vet the Examiner’s report • First Examination Report (FER) containing gist of the objections is issued within 6 months from the date of filing of request PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 140. Response from the Applicant • 12 months’ time, from the date of issue of FER, is available to the applicant to meet the objections • If objections are met, grant of patent is approved by the Controller – within a period of 1 month PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 141. Pre-grant Opposition • After publication, an opposition can be filed within a period of 6 months • Opportunity of hearing the opponent is also available PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 142. Examination of Pre-grant Opposition • Opposition (documents) is sent to the applicant • A period of 3 months is allowed for receipt of response PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 143. Consideration of Pre-grant Opposition • After examining the opposition and the submissions made during the hearing, Controller may – Either reject the opposition and grant the patent – Or accept the opposition and modify/reject the patent application • This is to be done within a period of 1 month from the date of completion of opposition proceedings
  • 144. Grant of a Patent • A certificate of patent is issued within 7 days • Grant of patent is published in the official journal
  • 145. STAGES - FILING TO GRANT OF PATENT PUBLICATION OF APPLICATION REQUEST FOR EXAMINATION GRANT OF PATENT 3rd Party Representation Revocation/Amendment OPPOSITION • PROMPTLY AFTER 18 MONTHS FROM P.D. • WITHIN 48 MONTHS FROM F.D. • ALL OBJECTIONS TO BE COMPLIED WITHIN 12 MONTHS • IF P.S.IS FILED C.S. TO BE FILED WITHIN 12MONTHS • WITHIN 12 MONTHS FILING OF APPLICATION PROVNL. / COMPLETE Decision of Controller EXAMINATION-ISSUE OF FER Appeal Appellate Board PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 146. Renewal Fee • To be paid within 3+6 months from date of recording in the register [sec 142 (4) ] • No fee for 1st and 2nd year • Renewal fee, on yearly basis, is required to be paid for 3rd to 20th for keeping the patent in force • Delay upto six months from due date permissible on payment of fee for extension of time • Patent lapses if renewal fee is not paid within the prescribed period PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 147. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 148. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 149. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 150. Indian Drug Regulatory System: Government of India Ministry of Health & Family Welfare DGHS Central Drugs Standard Control Organization (CDSCO) Ministry of Science & Technology Indian Council of Medical Research (ICMR) Council of Scientific & Industrial Research (CSIR) BARC (Radioactive) Ministry of Chemicals & Petrochemicals National Pharmaceutical Pricing Authority (NPPA) Department of Chemical & Petrochemicals (DCP) Department of Pharmaceuticals Ministry of Commerce & Industry Patent Office Dept. of Commerce & Pharmexil Controller General of Patent DGFT Ministry of Environment & Forest GEAC-[Genetic Engineering Approval Committee] Department of Biotechnology r-DNA Advisory Committee Review Committee Genetic Manipulation PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 151. Regulatory/Apex/Committee Functions CDSCO Central Drugs Standard Control Organization (1948) Laying down standards, Clearance of new drugs, CLAA items, Banning Drugs, Clinical Trails etc. ICMR Indian Council of Medical Research (1911) Formulates, Coordinates and Promotes biomedical research & Ethical Principles GEAC Genetic Engineering Approval Committee (1989) Manufacture, Use, Import of Hazards Microorganisms/Genetically Engineered Organisms or Cells DBT Department of Biotechnology (1986) It promote transgenic research, molecular biology of human genetic disorders, brain research, and commercialization of diagnostic kits and vaccines for communicable diseases AERB Atomic Energy Review Board (1983) Promotes Radio therapy & Research, Safety review for Gamma Irradiators (Devices) BARC Bhabha Atomic Research Centre (1967) Promotes Isotopes application in Medicine & also monitoring usage of radioactive materials DTAB Drug Technical Advisory Board (1950) To advise Central & State Govt. on Technical Matters arising out of the Drugs & Cosmetics RCGM Review Committee on Genetic Manipulation (1989) No Objection Certificate for Clinical Trial & also r-DNA strains, DCC Drug Consultative Committee (since 1951) Advisory Committee to DTAB and Central & State Govt. for uniform implementation of Various provisions of the ActPHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 152. Introduction to Ministry of Health & Family Welfare (MOH&FW) • MOH&FW comprises 04 departments each of which is headed by a Secretary to the Govt. of India – Department of Health & Family welfare – Department of AYUSH – Department of Health Research – Department of AIDS Control • CDSCO is a separate division comes under DGHS, headed by DCG(I) • Public health is one of the major objectives of Govt. of India and to achieve this it is important that drugs/vaccines are available to the public are Quality, Safety, Purity and Efficacious. 152 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 153. 153 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 154. Goa New Delhi Chennai CDSCO North Zone (Ghaziabad) Kolkata . CDSCO West Zone (Mumbai) CDSCO South Zone (Chennai) CDSCO East Zone (Kolkata) CDSCO, HQ • Hyderabad Ahmedabad *New Zonal Offices : 2 (Ahmedabad & Hyderabad) *Sub- Zonal Office : 3 *Port Offices/Airports : 11 *Central Laboratories : 6 35 SLAs= 29 States+ 6 UTs Bengaluru Geographical Location of CDSCO Chandigarh J&K HQ 154
  • 155. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 156. Functions of CDSCO Approval of new drugs and clinical trials Import Registration and Licensing License approving of Blood Banks, LVPs, Vaccines, r-DNA products & some Medical Devices (CLAA Scheme) Amendment to D &C Act and Rules Banning of drugs and cosmetics Grant of Test License, Personal License, NOCs for Export Testing of New Drugs 156 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 157. Functions of State Licensing Authorities Licensing of Manufacturing Site for Drugs including API and Finished Formulation Licensing of Establishment for sale or distribution of Drugs Approval of Drug Testing Laboratories Monitoring of Quality of Drugs and Cosmetics marketed in the country Investigation and prosecution in respect of contravention of legal provision Recall of sub-standard drugs 157 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 158. Principles of GLP and Regulatory requirements Objectives of GLP • GLP makes sure that the data submitted are a true reflection of the results that are obtained during the study. • GLP also makes sure that data is traceable. • Promotes international acceptance of tests. 158 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 159. What is GLP? • Good Laboratory Practice (GLP) deals with the organization, process and conditions under which laboratory studies are planned, performed, monitored, recorded, reported & archived. GLP practices are intended to promote the quality and validity of test data (part 58 CFR 21). OR • GLP is a quality system concerned with the organizational process and the conditions under which non clinical health & environmental safety studies are planned, performed, monitored, recorded, archived & reported. (Ref. Jurg P. Seiler-Switzerland, GLP, 2nd edition by Springer publication, 2005, Page 61). • Schedule L-I regulations and guidelines have a significant impact on the daily operation of an analytical laboratory. • GLP is a regulation. It is not only good analytical practice. Good analytical practice is important, but it is not enough. For example, the laboratory must have a specific organizational structure and procedures to perform and document laboratory work. The objective is not only quality of data but also traceability and integrity of data. But the biggest difference between GLP and Non-GLP work is the type and amount of documentation. 159 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 160. Pharmaceutical product Submitted to regulatory authority Verification Repetition of experiment or Reconstruction of all activities activities (Direct confirmation) (Indirect confirmation) Judgment taken Accept / Reject 160 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 161. Part 1 Management and infrastructure • Organization and management • Quality management system • Control of documentation • Records • Data-processing equipment • Personnel • Premises • Equipment, instruments and other devices • Contracts Part 2 Materials, equipment, instruments and other devices • Reagents • Reference substances and reference materials • Calibration, verifi cation of performance and • qualification of equipment, instruments and other devices • Traceability Part 3 Working procedures • Incoming samples • Analytical worksheet • Validation of analytical procedures • Testing • Evaluation of test results • Certificate of analysis • Retained samples Part 4 Safety • General rules 161 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 162. GLP Internal Quality System Audits General Requirements Premises Personal Equipments Chemicals and Reagents Quality System Microbiological Cultures Reference Materials Maintenance, Calibration, and Validation of Equipments Good House Keeping and SafetyManagement Review Standard Operating Procedures Protocols and Specifications Archive Raw Data Storage and Archival 162 PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 163. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 164. PHARMA MANAGEMENT & REGULATORY AFFAIRS
  • 165. PHARMA MANAGEMENT & REGULATORY AFFAIRS